• Something wrong with this record ?

Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology

JA. Hubacek,

. 2016 ; 592 (1) : 193-9. [pub] 20160802

Language English Country Netherlands

Document type Journal Article, Review

Persistent link   https://www.medvik.cz/link/bmc17013597

Apolipoprotein A5 (APOA5) is a small protein, expressed predominantly in the liver. In plasma, it is located on triglyceride rich lipoprotein particles (chylomicrones and VLDL) and on HDL. Plasma concentration of apolipoprotein A5 is very low, suggesting rather regulatory (activation of lipoprotein lipase, …) than structural function. APOA5 is an important determinant of plasma triglyceride concentration; this effect has been confirmed both on animal models, as well as on human studies. Minor alleles of three commonly analysed variants within this gene (rs662799, rs3135506, rs2075291) are associated with higher plasma TG values and increased risk of myocardial infarction, with some important interethnic differences observed. Further roles of APOA5; determination of BMI, diabetes and last but not least nutri- and pharmaco-genetic interactions are suggested, but without the definitive conclusions.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013597
003      
CZ-PrNML
005      
20170502103804.0
007      
ta
008      
170413s2016 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.gene.2016.07.070 $2 doi
035    __
$a (PubMed)27496343
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Hubacek, Jaroslav A $u Center for Experimental Medicine, Institute for Clinical and Experimental Medicine, Prague, Czech Republic. Electronic address: jahb@ikem.cz.
245    10
$a Apolipoprotein A5 fifteen years anniversary: Lessons from genetic epidemiology / $c JA. Hubacek,
520    9_
$a Apolipoprotein A5 (APOA5) is a small protein, expressed predominantly in the liver. In plasma, it is located on triglyceride rich lipoprotein particles (chylomicrones and VLDL) and on HDL. Plasma concentration of apolipoprotein A5 is very low, suggesting rather regulatory (activation of lipoprotein lipase, …) than structural function. APOA5 is an important determinant of plasma triglyceride concentration; this effect has been confirmed both on animal models, as well as on human studies. Minor alleles of three commonly analysed variants within this gene (rs662799, rs3135506, rs2075291) are associated with higher plasma TG values and increased risk of myocardial infarction, with some important interethnic differences observed. Further roles of APOA5; determination of BMI, diabetes and last but not least nutri- and pharmaco-genetic interactions are suggested, but without the definitive conclusions.
650    _2
$a apolipoprotein A-V $x krev $x genetika $x metabolismus $7 D000072040
650    _2
$a kardiovaskulární nemoci $x krev $x epidemiologie $x genetika $7 D002318
650    _2
$a lidé $7 D006801
650    12
$a jednonukleotidový polymorfismus $7 D020641
650    _2
$a triglyceridy $x krev $7 D014280
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
773    0_
$w MED00001888 $t Gene $x 1879-0038 $g Roč. 592, č. 1 (2016), s. 193-9
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27496343 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170502104130 $b ABA008
999    __
$a ok $b bmc $g 1200062 $s 974375
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 592 $c 1 $d 193-9 $e 20160802 $i 1879-0038 $m Gene $n Gene $x MED00001888
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Archiving options